163 related articles for article (PubMed ID: 30530568)
1. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
Alonso-Jimenez A; Kroon RHMJM; Alejaldre-Monforte A; Nuñez-Peralta C; Horlings CGC; van Engelen BGM; Olivé M; González L; Verges-Gil E; Paradas C; Márquez C; Garibaldi M; Gallano P; Rodriguez MJ; Gonzalez-Quereda L; Dominguez Gonzalez C; Vissing J; Fornander F; Eisum AV; García-Sobrino T; Pardo J; García-Figueiras R; Muelas N; Vilchez JJ; Kapetanovic S; Tasca G; Monforte M; Ricci E; Gomez MT; Bevilacqua JA; Diaz-Jara J; Zamorano II; Carlier RY; Laforet P; Pelayo-Negro A; Ramos-Fransi A; Martínez A; Marini-Bettolo C; Straub V; Gutiérrez G; Stojkovic T; Martín MA; Morís G; Fernández-Torrón R; Lopez De Munaín A; Cortes-Vicente E; Querol L; Rojas-García R; Illa I; Diaz-Manera J
J Neurol Neurosurg Psychiatry; 2019 May; 90(5):576-585. PubMed ID: 30530568
[TBL] [Abstract][Full Text] [Related]
2. Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy.
Fischmann A; Gloor M; Fasler S; Haas T; Rodoni Wetzel R; Bieri O; Wetzel S; Heinimann K; Scheffler K; Fischer D
J Neurol; 2011 Jul; 258(7):1333-40. PubMed ID: 21340522
[TBL] [Abstract][Full Text] [Related]
3. Muscle MRI in Patients With Oculopharyngeal Muscular Dystrophy: A Longitudinal Study.
Kroon RHMJM; Kalf JG; de Swart BJM; Heskamp L; de Rooy JWJ; van Engelen BGM; Horlings CGC
Neurology; 2024 Jan; 102(1):e207833. PubMed ID: 38165364
[TBL] [Abstract][Full Text] [Related]
4. Involvement of pelvic girdle and proximal leg muscles in early oculopharyngeal muscular dystrophy.
van der Sluijs BM; Lassche S; Knuiman GJ; Kusters B; Heerschap A; Hopman M; Schreuder TH; van Engelen BGM; Voermans NC
Neuromuscul Disord; 2017 Dec; 27(12):1099-1105. PubMed ID: 29102430
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of the muscle involvement along the disease progression in a large cohort of oculopharyngodistal myopathy compared to oculopharyngeal muscular dystrophy.
Eura N; Noguchi S; Ogasawara M; Kumutpongpanich T; Hayashi S; Nishino I;
J Neurol; 2023 Dec; 270(12):5988-5998. PubMed ID: 37634163
[TBL] [Abstract][Full Text] [Related]
6. Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials.
Diaz-Manera J; Fernandez-Torron R; LLauger J; James MK; Mayhew A; Smith FE; Moore UR; Blamire AM; Carlier PG; Rufibach L; Mittal P; Eagle M; Jacobs M; Hodgson T; Wallace D; Ward L; Smith M; Stramare R; Rampado A; Sato N; Tamaru T; Harwick B; Rico Gala S; Turk S; Coppenrath EM; Foster G; Bendahan D; Le Fur Y; Fricke ST; Otero H; Foster SL; Peduto A; Sawyer AM; Hilsden H; Lochmuller H; Grieben U; Spuler S; Tesi Rocha C; Day JW; Jones KJ; Bharucha-Goebel DX; Salort-Campana E; Harms M; Pestronk A; Krause S; Schreiber-Katz O; Walter MC; Paradas C; Hogrel JY; Stojkovic T; Takeda S; Mori-Yoshimura M; Bravver E; Sparks S; Bello L; Semplicini C; Pegoraro E; Mendell JR; Bushby K; Straub V;
J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1071-1081. PubMed ID: 29735511
[TBL] [Abstract][Full Text] [Related]
7. Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.
van der Sluijs BM; Raz V; Lammens M; van den Heuvel LP; Voermans NC; van Engelen BG
J Neuromuscul Dis; 2016 Mar; 3(1):101-109. PubMed ID: 27854203
[TBL] [Abstract][Full Text] [Related]
8. Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy.
Raz V; Sterrenburg E; Routledge S; Venema A; van der Sluijs BM; Trollet C; Dickson G; van Engelen BG; van der Maarel SM; Antoniou MN
BMC Neurol; 2013 Jul; 13():70. PubMed ID: 23815790
[TBL] [Abstract][Full Text] [Related]
9. Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy.
Galimberti V; Tironi R; Lerario A; Scali M; Del Bo R; Rodolico C; Brizzi T; Gibertini S; Maggi L; Mora M; Toscano A; Comi GP; Sciacco M; Moggio M; Peverelli L
Eur J Neurol; 2020 Apr; 27(4):709-715. PubMed ID: 31769567
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Quantitative MRI and Muscle Histopathology in Muscle Biopsies from Healthy Controls and Patients with IBM, FSHD and OPMD.
Lassche S; Küsters B; Heerschap A; Schyns MVP; Ottenheijm CAC; Voermans NC; van Engelen BGM
J Neuromuscul Dis; 2020; 7(4):495-504. PubMed ID: 32925090
[TBL] [Abstract][Full Text] [Related]
11. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres.
Trollet C; Anvar SY; Venema A; Hargreaves IP; Foster K; Vignaud A; Ferry A; Negroni E; Hourde C; Baraibar MA; 't Hoen PA; Davies JE; Rubinsztein DC; Heales SJ; Mouly V; van der Maarel SM; Butler-Browne G; Raz V; Dickson G
Hum Mol Genet; 2010 Jun; 19(11):2191-207. PubMed ID: 20207626
[TBL] [Abstract][Full Text] [Related]
12. Characterization of
Cruz-Aguilar M; Guerrero-de Ferran C; Tovilla-Canales JL; Nava-Castañeda A; Zenteno JC
J Investig Med; 2017 Mar; 65(3):705-708. PubMed ID: 27980005
[TBL] [Abstract][Full Text] [Related]
13. Dropped-head in recessive oculopharyngeal muscular dystrophy.
Garibaldi M; Pennisi EM; Bruttini M; Bizzarri V; Bucci E; Morino S; Talerico C; Stoppacciaro A; Renieri A; Antonini G
Neuromuscul Disord; 2015 Nov; 25(11):869-72. PubMed ID: 26494409
[TBL] [Abstract][Full Text] [Related]
14. Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients.
Gidaro T; Negroni E; Perié S; Mirabella M; Lainé J; Lacau St Guily J; Butler-Browne G; Mouly V; Trollet C
J Neuropathol Exp Neurol; 2013 Mar; 72(3):234-43. PubMed ID: 23399899
[TBL] [Abstract][Full Text] [Related]
15. Quantification of fat infiltration in oculopharyngeal muscular dystrophy: comparison of three MR imaging methods.
Gloor M; Fasler S; Fischmann A; Haas T; Bieri O; Heinimann K; Wetzel SG; Scheffler K; Fischer D
J Magn Reson Imaging; 2011 Jan; 33(1):203-10. PubMed ID: 21182140
[TBL] [Abstract][Full Text] [Related]
16. PABPN1 loss-of-function causes APA-shift in oculopharyngeal muscular dystrophy.
Shademan M; Mei H; van Engelen B; Ariyurek Y; Kloet S; Raz V
HGG Adv; 2024 Apr; 5(2):100269. PubMed ID: 38213032
[TBL] [Abstract][Full Text] [Related]
17. A case of rare recessive oculopharyngeal muscular dystrophy (OPMD) coexisting with hereditary neuropathy with liability to pressure palsies (HNPP).
Marsh EA; Robinson DO
Clin Neurol Neurosurg; 2008 May; 110(5):525-8. PubMed ID: 18358598
[TBL] [Abstract][Full Text] [Related]
18. Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies.
Abu-Baker A; Rouleau GA
Biochim Biophys Acta; 2007 Feb; 1772(2):173-85. PubMed ID: 17110089
[TBL] [Abstract][Full Text] [Related]
19. Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1.
García-Castañeda M; Vega AV; Rodríguez R; Montiel-Jaen MG; Cisneros B; Zarain-Herzberg A; Avila G
J Physiol; 2017 Jul; 595(13):4167-4187. PubMed ID: 28303574
[TBL] [Abstract][Full Text] [Related]
20. [Preferential distal muscle involvement in case of oculopharyngeal muscular dystrophy with (GCG) 13 expansion].
Nakashima D; Nakajima H; Ishida S; Sugino M; Kimura F; Hanafusa T
Rinsho Shinkeigaku; 2003 Sep; 43(9):560-3. PubMed ID: 14727564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
